Population-scale sequencing resolves correlates and determinants of latent Epstein-Barr Virus infection
Sherry S. Y. Nyeo(Memorial Sloan Kettering Cancer Center), Caleb A. Lareau(Gladstone Institutes), Meghana S. Pagadala(University of California San Diego), Kushal K. Dey(Memorial Sloan Kettering Cancer Center), Stewart MacArthur(AstraZeneca (United Kingdom)), Oliver S. Burren(AstraZeneca (United Kingdom)), Ryan S. Dhindsa(Baylor College of Medicine), Margarete A. Fabre(University of Cambridge), Jacob C. Gutierrez(Memorial Sloan Kettering Cancer Center), Quanli Wang, Leif S. Ludwig(Broad Institute), Erin M. Cumming(Memorial Sloan Kettering Cancer Center), Benjamin Hollis(AstraZeneca (United Kingdom)), Yifan Chen(Baylor College of Medicine), Slavé Petrovski(AstraZeneca (United Kingdom)), Thahmina Ali(City University of New York), Laura C. Kida(Memorial Sloan Kettering Cancer Center), Fengyuan Hu(Babraham Institute)
Cited by 1